M4MM

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

AYR Wellness Announces Leadership Changes

LOS ANGELES- AYR Wellness Inc., a U.S.-based multi-state cannabis operator, has announced recent adjustments to its executive team. Effective April 4, 2025, Steven M. Cohen stepped down as Interim Chief Executive Officer, a position he ...

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

U.S. Cannabis Industry: Growth and Puzzles Across States

LOS ANGELES— The cannabis landscape in the U.S. is rapidly shifting, with each state crafting its narrative. From Maryland's remarkable entry to Michigan's booming market, Illinois's unique challenges, and Colorado's stellar tax earnings, the industry's ...

Filament Health Refiles Q2 Financial Results

LOS ANGELES-- Filament Health Corp. has refiled its second-quarter financial results for the period ending June 30, 2023, following an initial filing on May 12, 2023. The revision was necessitated by changes in the accounting ...

COMPASS Pathways Q2 2023 Financial Analysis

LOS ANGELES-- COMPASS Pathways, a biotech firm in the psychedelic medicine sector, has been under the spotlight since its inception. This year, the company's trajectory remains robust, as evidenced by its recent financial report and ...

Subscribe To Our Newsletter